RBOT
Vicarious Surgical Inc.Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-02-20 | Sachs Adam David |
Director, President |
Sell↓
Filing footnotes — Class A Common Stock (Direct)
The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on May 19, 2022. The sale is mandated by the Issuer's election under its equity incentive plan to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. This figure is the weighted average sales price of multiple trades ranging from $1.845 to $2.290 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request. |
Class A Common Stock
|
942 |
| 2026-02-20 | Khalifa Sammy |
Director, Chief Technology Officer |
Sell↓
Filing footnotes — Class A Common Stock (Direct)
The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on May 19, 2022. The sale is mandated by the Issuer's election under its equity incentive plan to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. This figure is the weighted average sales price of multiple trades ranging from $1.845 to $2.290 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request. |
Class A Common Stock
|
754 |
| 2025-12-03 | Sachs Adam David |
Director, President |
Sell↓
Filing footnotes — Class A Common Stock (Direct)
The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on June 2, 2023. The sale is mandated by the Issuer's election under its equity incentive plan to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. This figure is the weighted average sales price of multiple trades ranging from $2.715 to $3.34 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request. |
Class A Common Stock
|
463 |
| 2025-12-03 | Khalifa Sammy |
Director, Chief Technology Officer |
Sell↓
Filing footnotes — Class A Common Stock (Direct)
The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on June 2, 2023. The sale is mandated by the Issuer's election under its equity incentive plan to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. This figure is the weighted average sales price of multiple trades ranging from $2.725 to $3.34 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request. |
Class A Common Stock
|
239 |
| 2025-11-20 | Khalifa Sammy |
Director, Chief Technology Officer |
Sell↓
Filing footnotes — Class A Common Stock (Direct)
The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on May 19, 2022. The sale is mandated by the Issuer's election under its equity incentive plan to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. This figure is the weighted average sales price of multiple trades ranging from $2.57 to $2.94 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request. |
Class A Common Stock
|
653 |
| 2025-11-20 | Sachs Adam David |
Director, President |
Sell↓
Filing footnotes — Class A Common Stock (Direct)
The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on May 19, 2022. The sale is mandated by the Issuer's election under its equity incentive plan to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. This figure is the weighted average sales price of multiple trades ranging from $2.54 to $2.94 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request. |
Class A Common Stock
|
816 |
| 2025-09-03 | Khalifa Sammy |
Director, Chief Technology Officer |
Sell↓
Filing footnotes — Class A Common Stock (Direct)
The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on June 2, 2023. The sale is mandated by the Issuer's election under its equity incentive plan to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. This figure is the weighted average sales price of multiple trades ranging from $5.60 to $5.84 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc.full information about the number of shares sold at each separate price upon request. |
Class A Common Stock
|
239 |
| 2025-09-03 | Sachs Adam David |
Director, President |
Sell↓
Filing footnotes — Class A Common Stock (Direct)
The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on June 2, 2023. The sale is mandated by the Issuer's election under its equity incentive plan to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. This figure is the weighted average sales price of multiple trades ranging from $5.64 to $5.87 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request. |
Class A Common Stock
|
463 |
| 2025-08-26 | Tang Donald F |
Director |
Sell↓
Filing footnotes — Class A Common Stock (Direct)
This figure is the weighted average sales price of multiple trades ranging from $6.64 to $7.15 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request. |
Class A Common Stock
|
2,753 |
| 2025-08-20 | Tang Donald F |
Director |
Sell↓
|
Class A Common Stock
|
2,059 |
| 2025-08-20 | Khalifa Sammy |
Director, Chief Technology Officer |
Sell↓
Filing footnotes — Class A Common Stock (Direct)
The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on May 19, 2022. The sale is mandated by the Issuer's election under its equity incentive plan to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. This figure is the weighted average sales price of multiple trades ranging from $5.90 to $6.32 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request. |
Class A Common Stock
|
653 |
| 2025-08-20 | Sachs Adam David |
Director, President |
Sell↓
Filing footnotes — Class A Common Stock (Direct)
The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on May 19, 2022. The sale is mandated by the Issuer's election under its equity incentive plan to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. This figure is the weighted average sales price of multiple trades ranging from $5.90 to $6.32 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request. |
Class A Common Stock
|
817 |
| 2025-08-19 | Tang Donald F |
Director |
Sell↓
|
Class A Common Stock
|
100 |
| 2025-08-07 | FROM STEPHEN |
Director, Executive Chairman |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The shares underlying this option vest as to 25% of the award on August 7, 2026, with the remainder vesting in equal monthly installments over the following 36 months, subject to the Reporting Person's continued service through each applicable vesting date. |
Stock Option (right to buy)
|
297,600 |
| 2025-08-07 | FROM STEPHEN |
Director, Executive Chairman |
Other↑
|
No Securities Owned
|
0 |
| 2025-06-27 | Doherty Joseph Edward |
Director |
Other↑
|
No Securities Owned
|
0 |
| 2025-06-27 | Clark Randolph A. |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
All of the shares underlying this option will vest on June 27, 2026, or one day prior to the Issuer's next Annual Meeting of Shareholders, whichever is earlier, subject to the Reporting Person's continued service through the applicable vesting date. |
Stock Option (right to buy)
|
8,003 |
| 2025-06-27 | Sachs Adam David |
Director, President |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The shares underlying this option vest in 48 equal monthly installments beginning on the one-month anniversary of the grant date, subject to the Reporting Person's continued service through the applicable vesting date. |
Stock Option (right to buy)
|
38,675 |
| 2025-06-27 | Ahmad Fuad |
Interim CFO |
Other↑
|
No Securities Owned
|
0 |
| 2025-06-27 | HUSS BEVERLY A |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
All of the shares underlying this option will vest on June 27, 2026, or one day prior to the Issuer's next Annual Meeting of Shareholders, whichever is earlier, subject to the Reporting Person's continued service through the applicable vesting date. |
Stock Option (right to buy)
|
5,335 |
| 2025-06-27 | Doherty Joseph Edward |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
All of the shares underlying this option will vest on June 27, 2026, or one day prior to the Issuer's next Annual Meeting of Shareholders, whichever is earlier, subject to the Reporting Person's continued service through the applicable vesting date. |
Stock Option (right to buy)
|
8,003 |
| 2025-06-27 | Tang Donald F |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
All of the shares underlying this option will vest on June 27, 2026, or one day prior to the Issuer's next Annual Meeting of Shareholders, whichever is earlier, subject to the Reporting Person's continued service through the applicable vesting date. |
Stock Option (right to buy)
|
5,335 |
| 2025-06-27 | Ho David D |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
All of the shares underlying this option will vest on June 27, 2026, or one day prior to the Issuer's next Annual Meeting of Shareholders, whichever is earlier, subject to the Reporting Person's continued service through the applicable vesting date. |
Stock Option (right to buy)
|
5,335 |
| 2025-06-27 | Ahmad Fuad |
Interim CFO |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
All of the shares underlying this option will vest on June 27, 2026, or one day prior to the Issuer's next Annual Meeting of Shareholders, whichever is earlier, subject to the Reporting Person's continued service through the applicable vesting date. |
Stock Option (right to buy)
|
8,003 |
| 2025-06-27 | Khalifa Sammy |
Director, Chief Technology Officer |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The shares underlying this option vest in 48 equal monthly installments beginning on the one-month anniversary of the grant date, subject to the Reporting Person's continued service through each applicable vesting date. |
Stock Option (right to buy)
|
25,025 |
| 2025-06-23 | Khalifa Sammy |
Director, Chief Technology Officer |
Sell↓
Filing footnotes — Class A Common Stock (Direct)
The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on November 23, 2021. This figure is the weighted average sales price of multiple trades ranging from $7.62 to $7.885 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request. |
Class A Common Stock
|
223 |
| 2025-06-23 | Sachs Adam David |
Director, President |
Sell↓
Filing footnotes — Class A Common Stock (Direct)
The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on November 23, 2021. This figure is the weighted average sales price of multiple trades ranging from $7.62 to $7.90 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc.with full information about the number of shares sold at each separate price upon request. |
Class A Common Stock
|
279 |
| 2025-06-03 | Sachs Adam David |
Director, President |
Sell↓
Filing footnotes — Class A Common Stock (Direct)
The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on June 2, 2023. This figure is the weighted average sales price of multiple trades ranging from $7.01 to $7.52 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request. |
Class A Common Stock
|
463 |
| 2025-06-03 | Khalifa Sammy |
Director, Chief Technology Officer |
Sell↓
Filing footnotes — Class A Common Stock (Direct)
The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on June 2, 2023. This figure is the weighted average sales price of multiple trades ranging from $7.01 to $7.52 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request. |
Class A Common Stock
|
239 |
| 2025-05-20 | Khalifa Sammy |
Director, Chief Technology Officer |
Sell↓
Filing footnotes — Class A Common Stock (Direct)
The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on May 19, 2022. This figure is the weighted average sales price of multiple trades ranging from $7.275 to $7.7625 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request. |
Class A Common Stock
|
653 |
| 2025-05-20 | Sachs Adam David |
Director, President |
Sell↓
Filing footnotes — Class A Common Stock (Direct)
The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on May 19, 2022. This figure is the weighted average sales price of multiple trades ranging from $7.275 to $7.86 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request. |
Class A Common Stock
|
817 |
| 2025-03-21 | Sachs Adam David |
Director, President |
Sell↓
Filing footnotes — Class A Common Stock (Direct)
The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on November 23, 2021. This figure is the weighted average sales price of multiple trades ranging from $7.73 to $8.09 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request. |
Class A Common Stock
|
161 |
| 2025-03-21 | Khalifa Sammy |
Director, Chief Technology Officer |
Sell↓
Filing footnotes — Class A Common Stock (Direct)
The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on November 23, 2021. This figure is the weighted average sales price of multiple trades ranging from $7.73 to $8.295 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request. |
Class A Common Stock
|
129 |
| 2025-03-03 | Sachs Adam David |
Director, President |
Sell↓
Filing footnotes — Class A Common Stock (Direct)
The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on June 2, 2023. This figure is the weighted average sales price of multiple trades ranging from $9.40 to $11.00 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request. |
Class A Common Stock
|
535 |
| 2025-03-03 | Mazzola John |
Chief Operating Officer |
Sell↓
Filing footnotes — Class A Common Stock (Direct)
The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on June 2, 2023. This figure is the weighted average sales price of multiple trades ranging from $9.40 to $11.00 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request. |
Class A Common Stock
|
264 |
| 2025-03-03 | Khalifa Sammy |
Director, Chief Technology Officer |
Sell↓
Filing footnotes — Class A Common Stock (Direct)
The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on June 2, 2023. This figure is the weighted average sales price of multiple trades ranging from $9.40 to $11.00 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request. |
Class A Common Stock
|
276 |
| 2025-02-20 | Khalifa Sammy |
Director, Chief Technology Officer |
Sell↓
Filing footnotes — Class A Common Stock (Direct)
The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on May 19, 2022. This figure is the weighted average sales price of multiple trades ranging from $14.085 to $15.50 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request. |
Class A Common Stock
|
754 |
| 2025-02-20 | Sachs Adam David |
Director, President |
Sell↓
Filing footnotes — Class A Common Stock (Direct)
The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on May 19, 2022. This figure is the weighted average sales price of multiple trades ranging from $14.08 to $15.50 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request. |
Class A Common Stock
|
943 |
| 2024-12-23 | Khalifa Sammy |
Director, Chief Technology Officer |
Sell↓
Filing footnotes — Class A Common Stock (Direct)
The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on November 23, 2021. This figure is the weighted average sales price of multiple trades ranging from $11.65 to $12.72 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request. |
Class A Common Stock
|
112 |
| 2024-12-23 | Sachs Adam David |
Director, President |
Sell↓
Filing footnotes — Class A Common Stock (Direct)
The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on November 23, 2021. This figure is the weighted average sales price of multiple trades ranging from $11.6500 to $12.77 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request. |
Class A Common Stock
|
139 |
| 2024-12-23 | Kelly William John |
CFO and Treasurer |
Sell↓
Filing footnotes — Class A Common Stock (Direct)
The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on November 23, 2021. This figure is the weighted average sales price of multiple trades ranging from $11.65 to $12.56 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request. |
Class A Common Stock
|
19 |
| 2024-12-03 | Khalifa Sammy |
Director, Chief Technology Officer |
Sell↓
Filing footnotes — Class A Common Stock (Direct)
The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on June 2, 2023. This figure is the weighted average sales price of multiple trades ranging from $12.60 to $14.63 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request. |
Class A Common Stock
|
239 |
| 2024-12-03 | Mazzola John |
Chief Operating Officer |
Sell↓
Filing footnotes — Class A Common Stock (Direct)
The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on June 2, 2023. This figure is the weighted average sales price of multiple trades ranging from $12.60 to $14.63 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request. |
Class A Common Stock
|
228 |
| 2024-12-03 | Sachs Adam David |
Director, President |
Sell↓
Filing footnotes — Class A Common Stock (Direct)
The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on June 2, 2023. This figure is the weighted average sales price of multiple trades ranging from $12.60 to $14.66 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request. |
Class A Common Stock
|
463 |
| 2024-12-03 | Kelly William John |
CFO and Treasurer |
Sell↓
Filing footnotes — Class A Common Stock (Direct)
The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on June 2, 2023. This figure is the weighted average sales price of multiple trades ranging from $12.60 to $14.66 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request. |
Class A Common Stock
|
218 |
| 2024-11-20 | Kelly William John |
CFO and Treasurer |
Sell↓
Filing footnotes — Class A Common Stock (Direct)
The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on May 19, 2022. This figure is the weighted average sales price of multiple trades ranging from $8.91 to $9.12 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request. |
Class A Common Stock
|
109 |
| 2024-11-20 | Khalifa Sammy |
Director, Chief Technology Officer |
Sell↓
Filing footnotes — Class A Common Stock (Direct)
The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on May 19, 2022. This figure is the weighted average sales price of multiple trades ranging from $8.825 to $9.220 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request. |
Class A Common Stock
|
653 |
| 2024-11-20 | Sachs Adam David |
Director, President |
Sell↓
Filing footnotes — Class A Common Stock (Direct)
The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on May 19, 2022. This figure is the weighted average sales price of multiple trades ranging from $8.81 to 9.26 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request. |
Class A Common Stock
|
817 |
| 2024-09-20 | Sachs Adam David |
Director, President |
Sell↓
Filing footnotes — Class A Common Stock (Direct)
The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on November 23, 2021. This figure is the weighted average sales price of multiple trades ranging from $5.67 to $5.95 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request. |
Class A Common Stock
|
139 |
| 2024-09-20 | Khalifa Sammy |
Director, Chief Technology Officer |
Sell↓
Filing footnotes — Class A Common Stock (Direct)
The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on November 23, 2021. This figure is the weighted average sales price of multiple trades ranging from $5.69 to $5.79 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request. |
Class A Common Stock
|
112 |